Fundz

Luminopia reported raising $4.07 Million in an initial SEC Form D filing, from an offering of $5.13 Million

PRIVATEOct 19, 2022$4.1M of $5.1M raised

Amount Raised

$4.07 Million

$4.07 Million sold, per SEC Form D (first sale Oct 5, 2022)

Round Type

Seed

CambridgeOtherBiotechnologyHealthcare

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as LUMINOPIA that raised within 45 days of this round, from Fundz verified event records.

  • Ingenia Therapeutics raised $7M on November 18, 2022.
  • Streamex Corp. raised $1.5M (Seed) on November 18, 2022.
  • SCA Health raised $18K (Pre-Seed) on November 18, 2022.
  • Venus Concept Inc. raised $6.7M on November 18, 2022.
  • Parabilis Medicines raised $178M on November 17, 2022.
  • Tellus Therapeutics raised $16M on November 17, 2022.

Who to call at LUMINOPIA, and when

A new round usually means LUMINOPIA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LUMINOPIA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LUMINOPIA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LUMINOPIA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LUMINOPIA

Location

625 MASSACHUSETTS AVENUE

Cambridge, Massachusetts, United States

About

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LUMINOPIA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsScott X., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for LUMINOPIA's next move

See what Strategic adds

LUMINOPIA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.